180 related articles for article (PubMed ID: 31548524)
1. Potential Roles of Antiphospholipid Antibodies in Generating Platelet-C4d in Systemic Lupus Erythematosus.
Liu CC; Schofield T; Tang A; Manzi S; Ahearn JM
Antibodies (Basel); 2017 Jul; 6(3):. PubMed ID: 31548524
[TBL] [Abstract][Full Text] [Related]
2. Blood Cell-Bound C4d as a Marker of Complement Activation in Patients With the Antiphospholipid Syndrome.
Lonati PA; Scavone M; Gerosa M; Borghi MO; Pregnolato F; Curreli D; Podda G; Femia EA; Barcellini W; Cattaneo M; Tedesco F; Meroni PL
Front Immunol; 2019; 10():773. PubMed ID: 31031764
[TBL] [Abstract][Full Text] [Related]
3. Platelet activation and anti-phospholipid antibodies collaborate in the activation of the complement system on platelets in systemic lupus erythematosus.
Lood C; Tydén H; Gullstrand B; Sturfelt G; Jönsen A; Truedsson L; Bengtsson AA
PLoS One; 2014; 9(6):e99386. PubMed ID: 24922069
[TBL] [Abstract][Full Text] [Related]
4. Serum complement activation on heterologous platelets is associated with arterial thrombosis in patients with systemic lupus erythematosus and antiphospholipid antibodies.
Peerschke EI; Yin W; Alpert DR; Roubey RA; Salmon JE; Ghebrehiwet B
Lupus; 2009 May; 18(6):530-8. PubMed ID: 19395455
[TBL] [Abstract][Full Text] [Related]
5. Antiphospholipid antibodies are persistently positive at high titers. Additive value of platelet-bound C4d.
Sciascia S; Bloch R; O'Malley T; Kammesheidt A; Alexander RV
Front Immunol; 2022; 13():949919. PubMed ID: 36032074
[TBL] [Abstract][Full Text] [Related]
6. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
[TBL] [Abstract][Full Text] [Related]
7. Platelet C4d is highly specific for systemic lupus erythematosus.
Navratil JS; Manzi S; Kao AH; Krishnaswami S; Liu CC; Ruffing MJ; Shaw PS; Nilson AC; Dryden ER; Johnson JJ; Ahearn JM
Arthritis Rheum; 2006 Feb; 54(2):670-4. PubMed ID: 16447243
[TBL] [Abstract][Full Text] [Related]
8. Complement deposition, C4d, on platelets is associated with vascular events in systemic lupus erythematosus.
Svenungsson E; Gustafsson JT; Grosso G; Rossides M; Gunnarsson I; Jensen-Urstad K; Larsson A; Ekdahl KN; Nilsson B; Bengtsson AA; Lood C
Rheumatology (Oxford); 2020 Nov; 59(11):3264-3274. PubMed ID: 32259250
[TBL] [Abstract][Full Text] [Related]
9. Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritis.
Cohen D; Koopmans M; Kremer Hovinga IC; Berger SP; Roos van Groningen M; Steup-Beekman GM; de Heer E; Bruijn JA; Bajema IM
Arthritis Rheum; 2008 Aug; 58(8):2460-9. PubMed ID: 18668574
[TBL] [Abstract][Full Text] [Related]
10. A Review of Complement Activation in SLE.
Weinstein A; Alexander RV; Zack DJ
Curr Rheumatol Rep; 2021 Feb; 23(3):16. PubMed ID: 33569681
[TBL] [Abstract][Full Text] [Related]
11. [Cardiac abnormalities in patients with systemic lupus erythematosus: the role of antiphospholipid antibodies].
Monti M; Borgognoni F; Pastacci L; Vincentelli GM
G Ital Cardiol (Rome); 2016 Dec; 17(12):1001-1007. PubMed ID: 28151504
[TBL] [Abstract][Full Text] [Related]
12. Antilymphocyte autoantibodies generate T cell-C4d signatures in systemic lupus erythematosus.
Liu CC; Manzi S; Ahearn JM
Transl Res; 2014 Dec; 164(6):496-507. PubMed ID: 25168018
[TBL] [Abstract][Full Text] [Related]
13. Elevated levels of soluble CD40 ligand are associated with antiphospholipid antibodies in patients with systemic lupus erythematosus.
Kim KJ; Baek IW; Yoon CH; Kim WU; Cho CS
Clin Exp Rheumatol; 2017; 35(5):823-830. PubMed ID: 28421990
[TBL] [Abstract][Full Text] [Related]
14. Increased C1q, C4 and C3 deposition on platelets in patients with systemic lupus erythematosus--a possible link to venous thrombosis?
Lood C; Eriksson S; Gullstrand B; Jönsen A; Sturfelt G; Truedsson L; Bengtsson AA
Lupus; 2012 Nov; 21(13):1423-32. PubMed ID: 22878256
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
[TBL] [Abstract][Full Text] [Related]
16. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
Cabiedes J; Cabral AR; Alarcón-Segovia D
J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
[TBL] [Abstract][Full Text] [Related]
18. Relation of platelet C4d with all-cause mortality and ischemic stroke in patients with systemic lupus erythematosus.
Kao AH; McBurney CA; Sattar A; Lertratanakul A; Wilson NL; Rutman S; Paul B; Navratil JS; Scioscia A; Ahearn JM; Manzi S
Transl Stroke Res; 2014 Aug; 5(4):510-8. PubMed ID: 24323718
[TBL] [Abstract][Full Text] [Related]
19. Antiphospholipid Antibodies are Associated with Low Levels of Complement C3 and C4 in Patients with Systemic Lupus Erythematosus.
Garabet L; Gilboe IM; Mowinckel MC; Jacobsen AF; Mollnes TE; Sandset PM; Jacobsen EM
Scand J Immunol; 2016 Aug; 84(2):95-9. PubMed ID: 27135178
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository.
Unlu O; Erkan D; Barbhaiya M; Andrade D; Nascimento I; Rosa R; Banzato A; Pengo V; Ugarte A; Gerosa M; Ji L; Efthymiou M; Branch DW; de Jesus GR; Tincani A; Belmont HM; Fortin PR; Petri M; Rodriguez E; Pons-Estel GJ; Knight JS; Atsumi T; Willis R; Zuily S; Tektonidou MG;
Arthritis Care Res (Hoboken); 2019 Jan; 71(1):134-141. PubMed ID: 29669399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]